<DOC>
	<DOCNO>NCT01700998</DOCNO>
	<brief_summary>Acute renal failure ( ARF ) serious common complication hospitalize patient , occur 25 % intensive care unit ( ICU ) patient . Hypomagnesemia common disorder , occur approximately 12 % hospitalized patient , incidence 60 % ICU patient . The majority patient asymptomatic hypomagnesemia , patient mild hypomagnesemia need treatment , correction underlying cause . Hypomagnesemia potentiate postischemic renal failure rat , associate , human , acute renal failure . To date , study demonstrate benefit maintain normal level magnesium incidence ARF critically ill patient . Thus , suggest treatment aim maintain normal magnesium level ICU stay decrease incidence ARF . We perform randomized clinical trial include patient admitted ICU , develop hypomagnesemia . It exclude study : patient young 18 year , participant study , pregnant woman , patient creatinine great equal 3.5 mg / dl dialysis , patient use intravenous contrast radiological study , patient weigh less 40kg , suffer advanced malignant disease , severe hypomagnesemia ( serum magnesium less equal 1.1 mg / dl ) , diagnosis Torsades de Pointes symptomatic hypomagnesemia prior randomization . Patients include study randomize one follow group : placebo ( saline solution 0.9 % ) 50 % Magnesium Sulfate . Patients receive administration 48 mEq Magnesium dilute 250 ml saline 0.9 % 24 hour infusion rate 10.4 ml / hr . Therapy continue 3 day , repeat ICU stay maintain magnesium level normal range . Placebo group receive exactly infusion saline administration . The therapy discontinue patient hypermagnesemia sign magnesium intoxication . The main outcome measurement occurrence ARF ICU stay .</brief_summary>
	<brief_title>Magnesium Replacement Therapy Prevent Acute Renal Failure Critically Ill Patients</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>All patient , clinical surgical , sign ( relative ) inform consent form , present hypomagnesemia ( serum magnesium 1.2 1.8 mg / dL ) , symptoms hypomagnesemia . Patients young 18 year , participant study , pregnant woman , patient admission plasma creatinine great equal 3.5 mg / dl dialysis , patient use intravenous contrast radiological study , patient weigh less 40kg , patient suffer advanced cancer , patient severe hypomagnesemia ( serum magnesium less equal 1.1 mg / dl ) , patient diagnosis Torsades de Pointes patient symptomatic hypomagnesemia prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>